Prognostic efficacy of inflammation-based markers in patients with curative colorectal cancer resection

doi:10.4251/wjgo.v9.i7.300

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9479)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

408

WORD

265

HTML

3785

Figures (1-1)

241

Tables (1-1)

224

Sum=4923

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

814

Download

1199

Sum=2013

Publishing Process of This Article

Item

Count

Browse

1018

Download

1525

Sum=2543

Jul 15, 2017 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Oncol. Jul 15, 2017; 9(7): 300-307
Published online Jul 15, 2017. doi: 10.4251/wjgo.v9.i7.300

Open in New Tab Full Size Figure Download Figure

Figure 1 Kaplan-Meier survival curve for overall survival in 183 patients undergoing potentially curative resection of colorectal cancer according to the prognostic nutritional index (A) and cancer antigen 19-9 (B). PNI: Prognostic nutritional index; CA19-9: Cancer antigen 19-9.

Citation: Akgül Ö, Çetinkaya E, Yalaza M, Özden S, Tez M. Prognostic efficacy of inflammation-based markers in patients with curative colorectal cancer resection. World J Gastrointest Oncol 2017; 9(7): 300-307
URL: https://www.wjgnet.com/1948-5204/full/v9/i7/300.htm
DOI: https://dx.doi.org/10.4251/wjgo.v9.i7.300